Pharmaceutical

Glaukos Announces Second Quarter 2023 Financial Results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the…

12 months ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023

RANCHO CUCAMONGA, CA / ACCESSWIRE / August 2, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release…

12 months ago

Safe Supply and Origin Therapeutics Announce Signing of Definitive Agreement

Vancouver, British Columbia--(Newsfile Corp. - August 2, 2023) -  Safe Supply Streaming Co. Ltd. ("Safe Supply") and Origin Therapeutics Holdings…

12 months ago

Ginkgo Bioworks Announces Date of Second Quarter 2023 Results Presentation

Presentation and Q&A session scheduled for post-market on Wednesday, August 9, 2023 BOSTON, Aug. 2, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE:…

12 months ago

Finalists Unveiled for 2023 BWB Awards: Biotech Week Boston’s Dazzling Gala on September 18th, 2023

BOSTON, MA / ACCESSWIRE / August 2, 2023 / September 18th, 2023: The prestigious BWB Awards at Biotech Week Boston…

12 months ago

Colin Bower Joins VivoSense as Chief Executive Officer

NEWPORT COAST, Calif.--(BUSINESS WIRE)--VivoSense, Inc. (“VivoSense”) is thrilled to announce Colin Bower as our new Chief Executive Officer and a…

12 months ago

REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men’s Health with Participation in Pineapple Healthcare’s “Butt Stuff Brunch with Dr. Carlton” August 5th

Napo Medical Affairs Team Member, who is an HIV/Mytesi® (Crofelemer) Patient, to Participate in Educational PanelSAN FRANCISCO, CA / ACCESSWIRE…

12 months ago

Syneos Health Stockholders Approve Agreement with Private Investment Consortium

MORRISVILLE, N.C., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading…

12 months ago

Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced the pricing…

12 months ago